Oxford Advanced Surfaces Group Announcements

Business Update & new Development Agreement signed

16 October 2008 07:00:06



RNS Number : 9551F Oxford Advanced Surfaces Group PLC 16 October 2008  
?
16 October 2008
Oxford Advanced Surfaces Group PLC (the 'Company')

Business Update and new Development Agreement signed
Oxford Advanced Surfaces Group plc announces the signing of its first development agreement in the biomedical sector. The group has been engaged by a European technology innovator working on novel medical devices in the field of gastroenterology. 

The Company is building a development portfolio across a broad range of applications and sectors, primarily through Joint Development Agreements ("JDAs") with leading players in a variety of markets but also advancing some in-house proofs of concept in selected  applications. Each of these projects, if they reach the market and are  commercially  successful, would represent a significant revenue and profit opportunity for both the customer and the Company.
 
With this new project we are now actively engaged in eleven  specific  development  programmes.  Eight of these are in sectors such as industrial materials, consumer goods,  electronics and now biomedical. A further three are in-house development applications of the Onto™ technology for use in photovoltaic devices and solid state lighting.  All of these programmes are in Stage 1 (Development of Materials). Whilst we expect a number of these projects to progress to Stage 2 (Process Development & Manufacturing Trials) some attrition will naturally occur. 

In addition we have a substantial pipeline of opportunities awaiting Initial Assessment or Proof of Concept ("PoC").  Many of these companies are global leaders in growth areas such as advanced materials, photovoltaics, solid state lighting and biomedical devices.  Our immediate aim is to build and maintain a portfolio of 15-20 active projects at any point in time and to begin to advance one or two projects to Stage 2 in 2009.  We are well on our way to achieving this goal.

The company is also involved in a number of collaborative or grant funded programmes.  Currently, the Company is participating in a collaborative research and development project with the University of Manchester and the Centre for Process Innovation in the field of plastic electronics, sponsoring a Knowledge Transfer Partnership in photovoltaics with The University of Oxford, and has just been awarded a grant from the Carbon Trust to develop applications in solid state lighting.

Marcelo Bravo, Chief Executive of Oxford Advances Surfaces Group plc, said:
"I am delighted to announce our first engagement into the biomedical devices market. This market has great potential for us from general applications of the Onto™ technology through to specialised biological coatings and biofilm and infection control."
Contacts: 
Oxford Advanced Surfaces Group plc
Marcelo Bravo, Chief Executive
www.oxfordadvancedsurfaces.com
Tel: +44 (0)1865 845807

Novum Securities Limited - Broker
Henry Turcan
Michael Brennan
Tel: +44 (0)20 7562 4700
Zimmerman Adams International - Nominated Adviser
Ray Zimmerman/Jonathan Evans
Tel: +44 (0)20 7398 2900

Notes to Editors
Oxford Advanced Surfaces Group plc
Oxford Advanced Surfaces Group plc develops and commercialises advanced materials and technology solutions leveraging breakthrough surface modification technology.
Onto™ technology exploits highly reactive chemistry allowing the rapid and convenient modification of the surface properties of a wide range of materials with a high degree of control over processing parameters.  Onto™ can be applied using standard commercial coating and curing techniques and is a versatile, effective, yet simple approach to deliver intelligent advanced materials.  This delivers permanent, dramatic and highly valuable changes to surface functionality. 
The company is working with commercial partners to develop applications in the industrial, consumer, electronics, alternative energy and biomedical sectors.  OASG was originally spun out of Oxford University in the United Kingdom and is now listed on London's Alternative Investment Market (AIM).
Website: www.oxfordsurfaces.com
This information is provided by RNSThe company news service from the London Stock Exchange  END  MSCEAKESFFNPFFE

All data suppied by Digital Look (15 minute delay)




Risk Warning

There is an extra risk of losing money when shares are bought in some smaller companies including 'Penny Shares'. There is a big difference between the buying price and the selling price of these shares. If they have to be sold immediately, you may get back much less than you paid for them or you may have difficulty in selling them. Past performance is not a reliable indicator of future results. The price may change quickly and it may go down as well as up. You could lose every penny put into a particular share.

The information contained above has been compiled from documented sources which are believed to be reliable but, due to their very nature, are subject to a degree of historical inaccuracy and have not been independently verified and cannot be guaranteed. The pages on this website are provided for information only. City Equities Limited will not accept responsibility for loss incurred by any person or body acting, or refraining from acting, as a result of information and/or opinions given anywhere on this website. Issued by City Equities Limited, Aldermary House, 10-15 Queen Street, London, EC4N 1TY. Registered in England. Registered No. 2742847. Registered Address: Amwell House, 19 Amwell Street, Hoddeson, Herts. EN11 8TS. City Equities Limited is Authorised and regulated by the Financial Services Authority. Registration No. 155051.